Emerging Issues in Inflammatory Bowel Diseases
-12 %

Emerging Issues in Inflammatory Bowel Diseases

 HC runder Rücken kaschiert
Besorgungstitel| Lieferzeit:3-5 Tage I

Unser bisheriger Preis:ORGPRICE: 245,03 €

Jetzt 215,63 €*

Alle Preise inkl. MwSt. | ggf. zzgl. Versand
HC runder Rücken kaschiert
A. Fraser
653 g
243x167x29 mm
Interdisciplinary symposium bringing together basic science and clinical applications
List of principal contributors List of chairpersons Preface SECTION I: ASIA - THE NEW FRONTIER FOR INFLAMMATORY BOWEL DISEASE.- 1 Inflammatory bowel disease: incidence and prevalence across Asia.- 2 Inflammatory bowel disease (IBD) in Asia: a comparison of phenotype and genotype with Western IBD.- 3 Inflammatory bowel disease in Asia: response to therapy.- 4 State-of-the-Art Lecture: Pathogenesis - why is inflammatory bowel disease increasing in Asia?.- SECTION II: DIAGNOSTIC CHALLENGES IN ASIA.- 5 Gastrointestinal tuberculosis versus Crohn's disease.- 6 Diagnostic challenges in Asia: intestinal Behçet's disease.- 7 Serodiagnosis of inflammatory bowel disease.- 8 State-of-the-Art Lecture: Anti-MAP therapy for Crohn's disease - saviour or non-event?.- SECTION III: KEY ISSUES IN THE PATHOGENESIS OF CROHN'S DISEASE.- 9 The search for an infectious cause of Crohn's disease.- 10 Disturbances in microbiota - cause or effect?.- 11 The role of defensins.- 12 Emerging issues in Crohn's disease: the central role of the macrophage.- 13 Connective tissue responses.- 14 State-of-the-Art Lecture: Genetics of Crohn's disease: lessons from an impaired barrier.- SECTION IV: INVESTIGATION OF THE GASTROINTESTINAL TRACT - EXPANDING THE HORIZONS .- 15 Faecal testing in inflammatory bowel disease.- 16 Magnetic resonance imaging in inflammatory bowel disease.- 17 The small bowel - capsule endoscopy in inflammatory bowel disease.- SECTION V: THE BASICS ON HOW-TO-TREAT INFLAMMATORY BOWEL DISEASE.- 18 Mild-to-moderate ulcerative colitis.- 19 The management of moderate to severe ulcerative colitis.- 20 Medical therapy of small bowel Crohn's disease.- 21 The basics - how to treat perianal Crohn's disease.- SECTION VI: THERAPEUTIC CHALLENGES IN ASIA.- 22 Application and evaluation of traditional Chinese medicine in inflammatory bowel disease.- 23 Immunosuppression in an endemically infected environment: tuberculosis.- 24 Therapeutic challenges in Asia:hepatitis B and C.- 25 Can Asia afford new and emerging therapies in inflammatory bowel disease?.- 26 State-of-the-Art Lecture: Inflammatory Bowel Disease - can the East learn from mistakes of the West.- SECTION VII: MAKING SENSE OF EMERGING THERAPEUTIC OPTIONS.- 27 Are biological drugs effective enough?.- 28 Are biologicals safe enough?.- 29 Step-up or step-down therapy in Crohn's disease?.- 30 New therapy for inflammatory bowel disease in pregnancy.- 31 State-of-the-Art Lecture: Irritable bowel syndrome: the new inflammatory bowel disease?.- SECTION VIII: NEW THERAPEUTIC APPROACHES FOR INFLAMMATORY BOWEL DISEASE - WILL THEY MAKE A DIFFERENCE?.- 32 Probiotics and inflammatory bowel disease.- 33 Enhancing barrier function in inflammatory bowel disease.- 34 Depleting phagocytes.- 35 Laparoscopic surgery for colitis.- Index
This book contains the proceedings of Falk Symposium 151 on 'Emerging Issues in Inflammatory Bowel Diseases', held in Sydney, Australia, March 2006, the first symposium of its kind both in the southern hemisphere and in the Asia-Pacific region. This interdisciplinary symposium brings together basic science and clinical applications. It presents the first major text where "East meets West" in IBD.